145 related articles for article (PubMed ID: 38539247)
1. CDCA5 promoted cell invasion and migration by activating TGF-β1 pathway in human ovarian cancer cells.
Zhang Q; Zhang R; Li Y; Yang X
J Ovarian Res; 2024 Mar; 17(1):68. PubMed ID: 38539247
[TBL] [Abstract][Full Text] [Related]
2. KLF5-mediated CDCA5 expression promotes tumor development and progression of epithelial ovarian carcinoma.
Chen X; Zhou M; Ma S; Wu H; Cai H
Exp Cell Res; 2023 Aug; 429(1):113645. PubMed ID: 37247719
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of CDCA5 Can Inhibit Cell Proliferation, Migration, and Invasion, and Induce Apoptosis of Prostate Cancer Cells.
Chong Y; Xue L
Crit Rev Eukaryot Gene Expr; 2021; 31(1):29-40. PubMed ID: 33639053
[TBL] [Abstract][Full Text] [Related]
4. CDCA5 promotes the progression of prostate cancer by affecting the ERK signalling pathway.
Ji J; Shen T; Li Y; Liu Y; Shang Z; Niu Y
Oncol Rep; 2021 Mar; 45(3):921-932. PubMed ID: 33650660
[TBL] [Abstract][Full Text] [Related]
5. CDCA5 is negatively regulated by miR-326 and boosts ovarian cancer progression.
Gao A; Hu Y; Zhu W
J BUON; 2021; 26(2):544-552. PubMed ID: 34077004
[TBL] [Abstract][Full Text] [Related]
6. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.
Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K
Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-Dependent Kinase 1 (CDK1) is Co-Expressed with CDCA5: Their Functions in Gastric Cancer Cell Line MGC-803.
Huang Z; Zhang S; Du J; Zhang X; Zhang W; Huang Z; Ouyang P
Med Sci Monit; 2020 Aug; 26():e923664. PubMed ID: 32759885
[TBL] [Abstract][Full Text] [Related]
8. Loss of cell division cycle‑associated 5 promotes cell apoptosis by activating DNA damage response in clear cell renal cell carcinoma.
Huang X; Huang Y; Lv Z; Wang T; Feng H; Wang H; Du S; Wu S; Shen D; Wang C; Li H; Wang B; Ma X; Zhang X
Int J Oncol; 2022 Jul; 61(1):. PubMed ID: 35642672
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma.
Tokuzen N; Nakashiro K; Tanaka H; Iwamoto K; Hamakawa H
Oncotarget; 2016 Jan; 7(3):2343-53. PubMed ID: 26497678
[TBL] [Abstract][Full Text] [Related]
10. Systematic cancer-testis gene expression analysis identified CDCA5 as a potential therapeutic target in esophageal squamous cell carcinoma.
Xu J; Zhu C; Yu Y; Wu W; Cao J; Li Z; Dai J; Wang C; Tang Y; Zhu Q; Wang J; Wen W; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; He Z; Pan X; Wei H; Zhu Y; He Y; Que J; Luo J; Chen L; Wang W
EBioMedicine; 2019 Aug; 46():54-65. PubMed ID: 31324603
[TBL] [Abstract][Full Text] [Related]
11. Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer.
Zhang L; Zhou D; Guan W; Ren W; Sun W; Shi J; Lin Q; Zhang J; Qiao T; Ye Y; Wu Y; Zhang Y; Zuo X; Connor KL; Xu G
Cell Death Dis; 2017 Dec; 8(12):3214. PubMed ID: 29238081
[TBL] [Abstract][Full Text] [Related]
12. KLF8 is activated by TGF-β1 via Smad2 and contributes to ovarian cancer progression.
Cherukunnath A; Davargaon RS; Ashraf R; Kamdar U; Srivastava AK; Tripathi PP; Chatterjee N; Kumar S
J Cell Biochem; 2022 May; 123(5):921-934. PubMed ID: 35293014
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis.
Xie W; Zhang L; Shen J; Lai F; Han W; Liu X
BMC Cancer; 2024 May; 24(1):551. PubMed ID: 38693472
[TBL] [Abstract][Full Text] [Related]
14. An integrated model of CDCA5 and FOXM1 expression combined with a residual disease that predicts prognosis in ovarian cancer patients.
Zhang Q; Zhang R; Liu M; Wu H; Yang B
Cell Mol Biol (Noisy-le-grand); 2023 Oct; 69(10):143-149. PubMed ID: 37953569
[TBL] [Abstract][Full Text] [Related]
15. LINK-A lncRNA promotes migration and invasion of ovarian carcinoma cells by activating TGF-β pathway.
Ma J; Xue M
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30061183
[No Abstract] [Full Text] [Related]
16. Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1.
Zhang Z; Shen M; Zhou G
Biochem Biophys Res Commun; 2018 Feb; 496(2):482-489. PubMed ID: 29326043
[TBL] [Abstract][Full Text] [Related]
17. UNC119 promoted cell growth and migration by Wnt/β-catenin signal and TGF-β/EMT signal pathway in hepatocellular carcinoma.
Liu ZH; Zhang YF; Xu ZD; Z H L; Y F Z; Z D X
J BUON; 2018; 23(6):1717-1724. PubMed ID: 30610799
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation and activation of cell division cycle associated 5 by mitogen-activated protein kinase play a crucial role in human lung carcinogenesis.
Nguyen MH; Koinuma J; Ueda K; Ito T; Tsuchiya E; Nakamura Y; Daigo Y
Cancer Res; 2010 Jul; 70(13):5337-47. PubMed ID: 20551060
[TBL] [Abstract][Full Text] [Related]
19. P76RBE silencing inhibits ovarian cancer cell proliferation, migration, and invasion via suppressing the integrin β1/NF-κB pathway.
Yan L; He Z; Li W; Liu N; Gao S
Cell Cycle; 2021 Sep; 20(18):1875-1889. PubMed ID: 34382920
[TBL] [Abstract][Full Text] [Related]
20. SPOP promotes CDCA5 degradation to regulate prostate cancer progression via the AKT pathway.
Luo Z; Wang J; Zhu Y; Sun X; He C; Cai M; Ma J; Wang Y; Han S
Neoplasia; 2021 Oct; 23(10):1037-1047. PubMed ID: 34509929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
